Lv41
640 积分 2023-07-28 加入
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
4小时前
已完结
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
4小时前
已完结
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
4小时前
已完结
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
4小时前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
10天前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
16天前
已完结
TASL has a key role in SLE
1个月前
已完结
Anti-cytokine autoantibodies: mechanistic insights and disease associations
1个月前
已完结
New perspectives on the origins and heterogeneity of mast cells
1个月前
已完结
Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
1个月前
已完结
皖公网安备34019202002308
